Proxibarbital: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 26: Line 26:
| routes_of_administration =  
| routes_of_administration =  
}}
}}
                  __NOTOC__
{{SI}}
{{SI}}
{{EH}}
{{CMG}}


==Overview==
==Overview==
Line 33: Line 34:


== References ==
== References ==
<references />
{{reflist|2}}
 
 


{{barbiturates}}
{{Hypnotics and sedatives}}
[[Category:Barbiturates]]
[[Category:Barbiturates]]
[[Category:Drug]]
[[Category:Sedatives]]
[[Category:Sedatives]]
{{WH}}
{{WS}}

Latest revision as of 14:29, 8 April 2015

Proxibarbital
Clinical data
SynonymsProxibarbital, Centralgol, Ipronal, 5-Allyl-5-(β-hydroxypropyl)barbituric acid
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H14N2O4
Molar mass226.229 g/mol

WikiDoc Resources for Proxibarbital

Articles

Most recent articles on Proxibarbital

Most cited articles on Proxibarbital

Review articles on Proxibarbital

Articles on Proxibarbital in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Proxibarbital

Images of Proxibarbital

Photos of Proxibarbital

Podcasts & MP3s on Proxibarbital

Videos on Proxibarbital

Evidence Based Medicine

Cochrane Collaboration on Proxibarbital

Bandolier on Proxibarbital

TRIP on Proxibarbital

Clinical Trials

Ongoing Trials on Proxibarbital at Clinical Trials.gov

Trial results on Proxibarbital

Clinical Trials on Proxibarbital at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Proxibarbital

NICE Guidance on Proxibarbital

NHS PRODIGY Guidance

FDA on Proxibarbital

CDC on Proxibarbital

Books

Books on Proxibarbital

News

Proxibarbital in the news

Be alerted to news on Proxibarbital

News trends on Proxibarbital

Commentary

Blogs on Proxibarbital

Definitions

Definitions of Proxibarbital

Patient Resources / Community

Patient resources on Proxibarbital

Discussion groups on Proxibarbital

Patient Handouts on Proxibarbital

Directions to Hospitals Treating Proxibarbital

Risk calculators and risk factors for Proxibarbital

Healthcare Provider Resources

Symptoms of Proxibarbital

Causes & Risk Factors for Proxibarbital

Diagnostic studies for Proxibarbital

Treatment of Proxibarbital

Continuing Medical Education (CME)

CME Programs on Proxibarbital

International

Proxibarbital en Espanol

Proxibarbital en Francais

Business

Proxibarbital in the Marketplace

Patents on Proxibarbital

Experimental / Informatics

List of terms related to Proxibarbital

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Proxibarbital (Ipronal) is a barbiturate derivative invented in the 1970s. It has sedative, hypnotic and anticonvulsant properties, and was used in the treatment of migraine headaches in a similar manner to butalbital.[1]

References

  1. Sulman FG, Pfeifer Y, Tal E. Migraine therapy by enzyme induction with proxibarbital (German). Therapie die Gegenwart. 1976 Dec;115(12):2088-103.